Intra-Cellular Therapies Overview

Intra-Cellular Therapies Selling, General & Admin

Selling, General & Admin expenses for ITCI.

Quarterly SG&A Expenses

$137.73M

↑ 31.52% YoY

As of Dec 31, 2024

Annual SG&A Expenses (TTM)

$504.49M

↑ 23.09% YoY

Trailing 12 months ending Dec 31, 2024

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin